GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

NCT06921317 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open-Angle Glaucoma (POAG)

Interventions

DRUG: GVB-2001-high dose
DRUG: GVB-2001-low dose

Sponsor

IVIEW Therapeutics Inc.

Collaborators

[object Object]